These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 9853979)

  • 1. Modeling INR data to predict maintenance fluindione dosage.
    Comets E; Mentré F; Pousset F; Diquet B; Montalescot G; Ankri A; Mallet A; Lechat P
    Ther Drug Monit; 1998 Dec; 20(6):631-9. PubMed ID: 9853979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Determination of regimen fluindione needed for anticoagulation in the elderly].
    Lechowski L; Teillet L; Harboun M; Tortrat D; Forette B
    Rev Med Interne; 2002 Dec; 23(12):1022-6. PubMed ID: 12504240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of fluindione maintenance dosage hampered by large intraindividual variability.
    Comets E; Pousset F; Mentré F; Diquet B; Ankri A; Mallet A; Lechat P
    Ther Drug Monit; 2000 Dec; 22(6):668-75. PubMed ID: 11128234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic and pharmacodynamic variability of fluindione in octogenarians.
    Comets E; Diquet B; Legrain S; Huisse MG; Godon A; Bruhat C; Chauveheid MP; Delpierre S; Duval X; Berrut G; Verstuyft C; Aumont MC; Mentré F
    Clin Pharmacol Ther; 2012 May; 91(5):777-86. PubMed ID: 22472992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beraprost sodium-fluindione combination in healthy subjects: pharmacokinetic and pharmacodynamic aspects.
    Warot D; Berlin I; Aymard G; Ankri A; Fabry C; Besse B; Lechat P; Diquet B
    Fundam Clin Pharmacol; 2000; 14(3):231-6. PubMed ID: 15602800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Population pharmacokinetic-pharmacodynamic analysis of fluindione in patients.
    Mentré F; Pousset F; Comets E; Plaud B; Diquet B; Montalescot G; Ankri A; Mallet A; Lechat P
    Clin Pharmacol Ther; 1998 Jan; 63(1):64-78. PubMed ID: 9465843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of a mobile electronic assistant to aid in fluindione prescription: the INRPlus cluster randomized trial.
    Imbert P; Pernod G; Jacquet JP; Bailly C; Laporte S; Lievre M;
    Thromb Res; 2014 May; 133(5):756-61. PubMed ID: 24582071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predicting daily maintenance dose of fluindione, an oral anticoagulant drug.
    Cazaux V; Gauthier B; Elias A; Lefebvre D; Tredez J; Nguyen F; Cambus JP; Boneu B; Boccalon H
    Thromb Haemost; 1996 May; 75(5):731-3. PubMed ID: 8725714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticoagulant (fluindione)-aspirin combination in patients with high-risk atrial fibrillation. A randomized trial (Fluindione, Fibrillation Auriculaire, Aspirin et Contraste Spontané; FFAACS).
    Lechat P; Lardoux H; Mallet A; Sanchez P; Derumeaux G; Lecompte T; Maillard L; Mas JL; Mentre F; Pousset F; Lacomblez L; Pisica G; Solbes-Latourette S; Raynaud P; Chaumet-Riffaud P;
    Cerebrovasc Dis; 2001; 12(3):245-52. PubMed ID: 11641591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potentiation of fluindione or warfarin by dexamethasone in multiple myeloma and AL amyloidosis.
    Sellam J; Costedoat-Chalumeau N; Amoura Z; Aymard G; Choquet S; Trad S; Vignes BL; Hulot JS; Berenbaum F; Lechat P; Cacoub P; Ankri A; Mariette X; Leblond V; Piette JC
    Joint Bone Spine; 2007 Oct; 74(5):446-52. PubMed ID: 17692552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potentiation of vitamin K antagonists by high-dose intravenous methylprednisolone.
    Costedoat-Chalumeau N; Amoura Z; Aymard G; Sevin O; Wechsler B; Cacoub P; Du LT; Diquet B; Ankri A; Piette JC
    Ann Intern Med; 2000 Apr; 132(8):631-5. PubMed ID: 10766681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antithrombotic efficacy of the vitamin K antagonist fluindione in a human Ex vivo model of arterial thrombosis : effect of anticoagulation level and combination therapy with aspirin.
    Bossavy JP; Sakariassen KS; Thalamas C; Boneu B; Cadroy Y
    Arterioscler Thromb Vasc Biol; 1999 Sep; 19(9):2269-75. PubMed ID: 10479672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Acenocoumarol (Sintrom) and fluinidione (Previscan) in pediatrics after cardiac surgical procedures].
    Piquet P; Losay J; Doubine S
    Arch Pediatr; 2002 Nov; 9(11):1137-44. PubMed ID: 12503504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of venous thrombosis with low molecular weight heparin and fluindione].
    Fiessinger JN; Paul JF; Alhenc-Gelas M; Veyssier C; Martin JB; Aiach M
    Presse Med; 1992 Jan; 21(2):65-8. PubMed ID: 1311080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Esomeprazole-induced resistance to fluindione: An unrecognized interaction].
    Ayme-Dietrich E; Aubertin-Kirch G; Andrès E; Monassier L
    Therapie; 2016 Jun; 71(3):337-41. PubMed ID: 27235659
    [No Abstract]   [Full Text] [Related]  

  • 16. Descriptive analysis of the process and quality of oral anticoagulation management in real-life practice in patients with chronic non-valvular atrial fibrillation: the international study of anticoagulation management (ISAM).
    Ansell J; Hollowell J; Pengo V; Martinez-Brotons F; Caro J; Drouet L
    J Thromb Thrombolysis; 2007 Apr; 23(2):83-91. PubMed ID: 17221328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can colchicine potentiate the anticoagulant effect of fluindione?
    Gras-Champel V; Ohlmann P; Polard E; Wiesel ML; Imbs JL; Andréjak M
    Eur J Clin Pharmacol; 2005 Aug; 61(7):555-6. PubMed ID: 16007421
    [No Abstract]   [Full Text] [Related]  

  • 18. Audit of correction of high INR in an anticoagulation clinic.
    Hirri HM; Green PJ
    Clin Lab Haematol; 2005 Jun; 27(3):172-6. PubMed ID: 15938722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Personalized versus non-personalized computerized decision support system to increase therapeutic quality control of oral anticoagulant therapy: an alternating time series analysis.
    Colombet I; Bura-Rivière A; Chatila R; Chatellier G; Durieux P;
    BMC Health Serv Res; 2004 Sep; 4(1):27. PubMed ID: 15456515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prospective study of oral anticoagulation control in 110 very elderly hospitalized patients and of risk factors for poor control].
    Vogel T; Coriol V; Kaltenbach G; Kiesmann M; Berthel M
    Presse Med; 2008 Dec; 37(12):1723-30. PubMed ID: 18644323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.